No image published for this recall
Quantum blue anti-infliximab
Official notice
14 Feb 2022
Last checked
14 Feb 2022
An official Health Canada notice concerns Quantum blue anti-infliximab. Positive, instead of negative, results have been reported by customers for the low control and patient samples for Quantum Blue® Anti-Infliximab production Series 1107. The increased false-positive rate was confirmed internally at Bühlmann. Approximately 80% of low control results and 24% of negative patients' samples are now expected to be false positive. Recall start date: Jan 17, 2022 Published 2022-02-14.
What to do now
Contact the manufacturer if you require additional information.
Recall number
63919
Official notice
2022-02-14
The hazard
The hazard
Positive, instead of negative, results have been reported by customers for the low control and patient samples for Quantum Blue® Anti-Infliximab production Series 1107. The increased false-positive rate was confirmed internally at Bühlmann. Approximately 80% of low control results and 24% of negative patients' samples are now expected to be false positive. Recall start date: Jan 17, 2022
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Buhlmann Laboratories, Quantum Blue Anti-infliximab.
Source & status
Source & status
Source
Tier
Category
Classification
App estimate
Recall details
Recall details
Recall number
Classification
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
Anti-gm1 autoantibodies elisa ivd test
20 Sept 2022Quantum blue adalimumab assay
Intramedullary bone saw blade assembly
Abiomed introducer kits with impella heart pumps
Image: Health Canada recall noticeImportation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)
Faradrive™ steerable sheath
Cook medical beacon® tip centimeter sizing catheter
Alecensaro (alectinib) and the risk of severe hypertriglyceridemia
Medline convenience kits containing namic ra syringes
Image: Health Canada recall noticeImportation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 14 Feb 2022. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
